View in EDS

Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.

Saved in:
Bibliographic Details
Title: Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.
Authors: Spring LM; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Tolaney SM; Dana-Farber Cancer Institute, Harvard Medical School, Boston., Fell G; Dana-Farber Cancer Institute, Harvard Medical School, Boston., Bossuyt V; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Abelman RO; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Wu B; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Maheswaran S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Trippa L; Dana-Farber Cancer Institute, Harvard Medical School, Boston., Comander A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Mulvey T; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., McLaughlin S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Ryan P; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Ryan L; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Abraham E; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Rosenstock A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Garrido-Castro AC; Dana-Farber Cancer Institute, Harvard Medical School, Boston., Lynce F; Dana-Farber Cancer Institute, Harvard Medical School, Boston., Moy B; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Isakoff SJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Tung N; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston., Mittendorf EA; Brigham and Women's Hospital, Harvard Medical School, Boston., Ellisen LW; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston; Ludwig Center, Harvard Medical School, Boston, USA., Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston. Electronic address: Bardia.Aditya@mgh.harvard.edu.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Mar; Vol. 35 (3), pp. 293-301. Date of Electronic Publication: 2023 Dec 12.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38092228
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Spring+LM%22">Spring LM</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Tolaney+SM%22">Tolaney SM</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Fell+G%22">Fell G</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Bossuyt+V%22">Bossuyt V</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Abelman+RO%22">Abelman RO</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Wu+B%22">Wu B</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Maheswaran+S%22">Maheswaran S</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Trippa+L%22">Trippa L</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Comander+A%22">Comander A</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Mulvey+T%22">Mulvey T</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22McLaughlin+S%22">McLaughlin S</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Ryan+P%22">Ryan P</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Ryan+L%22">Ryan L</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Abraham+E%22">Abraham E</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Rosenstock+A%22">Rosenstock A</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Garrido-Castro+AC%22">Garrido-Castro AC</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Lynce+F%22">Lynce F</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Moy+B%22">Moy B</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Isakoff+SJ%22">Isakoff SJ</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Tung+N%22">Tung N</searchLink>; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Mittendorf+EA%22">Mittendorf EA</searchLink>; Brigham and Women's Hospital, Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Ellisen+LW%22">Ellisen LW</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston; Ludwig Center, Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Bardia+A%22">Bardia A</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston. Electronic address: Bardia.Aditya@mgh.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2024 Mar; Vol. 35 (3), pp. 293-301. <i>Date of Electronic Publication: </i>2023 Dec 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38092228
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2023.11.018
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 293
    Titles:
      – TitleFull: Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Spring LM
      – PersonEntity:
          Name:
            NameFull: Tolaney SM
      – PersonEntity:
          Name:
            NameFull: Fell G
      – PersonEntity:
          Name:
            NameFull: Bossuyt V
      – PersonEntity:
          Name:
            NameFull: Abelman RO
      – PersonEntity:
          Name:
            NameFull: Wu B
      – PersonEntity:
          Name:
            NameFull: Maheswaran S
      – PersonEntity:
          Name:
            NameFull: Trippa L
      – PersonEntity:
          Name:
            NameFull: Comander A
      – PersonEntity:
          Name:
            NameFull: Mulvey T
      – PersonEntity:
          Name:
            NameFull: McLaughlin S
      – PersonEntity:
          Name:
            NameFull: Ryan P
      – PersonEntity:
          Name:
            NameFull: Ryan L
      – PersonEntity:
          Name:
            NameFull: Abraham E
      – PersonEntity:
          Name:
            NameFull: Rosenstock A
      – PersonEntity:
          Name:
            NameFull: Garrido-Castro AC
      – PersonEntity:
          Name:
            NameFull: Lynce F
      – PersonEntity:
          Name:
            NameFull: Moy B
      – PersonEntity:
          Name:
            NameFull: Isakoff SJ
      – PersonEntity:
          Name:
            NameFull: Tung N
      – PersonEntity:
          Name:
            NameFull: Mittendorf EA
      – PersonEntity:
          Name:
            NameFull: Ellisen LW
      – PersonEntity:
          Name:
            NameFull: Bardia A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2024 Mar
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1569-8041
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1